190 related articles for article (PubMed ID: 33416947)
1. Absolute quantification of tumor-infiltrating immune cells in high-grade glioma identifies prognostic and radiomics values.
Kim AR; Choi KS; Kim MS; Kim KM; Kang H; Kim S; Chowdhury T; Yu HJ; Lee CE; Lee JH; Lee ST; Won JK; Kim JW; Kim YH; Kim TM; Park SH; Choi SH; Shin EC; Park CK
Cancer Immunol Immunother; 2021 Jul; 70(7):1995-2008. PubMed ID: 33416947
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging-based radiomic features for extrapolating infiltration levels of immune cells in lower-grade gliomas.
Zhang X; Liu S; Zhao X; Shi X; Li J; Guo J; Niedermann G; Luo R; Zhang X
Strahlenther Onkol; 2020 Oct; 196(10):913-921. PubMed ID: 32025804
[TBL] [Abstract][Full Text] [Related]
3. Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology.
Mehani B; Asanigari S; Chung HJ; Dazelle K; Singh A; Hannenhalli S; Aldape K
Acta Neuropathol Commun; 2022 Feb; 10(1):19. PubMed ID: 35144680
[TBL] [Abstract][Full Text] [Related]
4. MRI-derived radiomics assessing tumor-infiltrating macrophages enable prediction of immune-phenotype, immunotherapy response and survival in glioma.
Chen D; Zhang R; Huang X; Ji C; Xia W; Qi Y; Yang X; Lin L; Wang J; Cheng H; Tang W; Yu J; Hoon DSB; Zhang J; Gao X; Yao Y
Biomark Res; 2024 Jan; 12(1):14. PubMed ID: 38291499
[TBL] [Abstract][Full Text] [Related]
5. Radiomic profiles in diffuse glioma reveal distinct subtypes with prognostic value.
Lin P; Peng YT; Gao RZ; Wei Y; Li XJ; Huang SN; Fang YY; Wei ZX; Huang ZG; Yang H; Chen G
J Cancer Res Clin Oncol; 2020 May; 146(5):1253-1262. PubMed ID: 32065261
[TBL] [Abstract][Full Text] [Related]
6. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
Park CJ; Han K; Kim H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK
Eur Radiol; 2020 Dec; 30(12):6464-6474. PubMed ID: 32740813
[TBL] [Abstract][Full Text] [Related]
7. Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction.
Choi YS; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Jain R; Lee SK
Eur Radiol; 2020 Jul; 30(7):3834-3842. PubMed ID: 32162004
[TBL] [Abstract][Full Text] [Related]
8. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
[TBL] [Abstract][Full Text] [Related]
9. Improving survival prediction of high-grade glioma via machine learning techniques based on MRI radiomic, genetic and clinical risk factors.
Tan Y; Mu W; Wang XC; Yang GQ; Gillies RJ; Zhang H
Eur J Radiol; 2019 Nov; 120():108609. PubMed ID: 31606714
[TBL] [Abstract][Full Text] [Related]
10. Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma.
Zhou J; Pei X; Yang Y; Wang Z; Gao W; Ye R; Zhang X; Liu J; Liu Z; Yang X; Tao J; Gu C; Hu W; Chan FL; Li X; Mao J; Wu D
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858847
[TBL] [Abstract][Full Text] [Related]
11. Correlation of immune phenotype with IDH mutation in diffuse glioma.
Berghoff AS; Kiesel B; Widhalm G; Wilhelm D; Rajky O; Kurscheid S; Kresl P; Wöhrer A; Marosi C; Hegi ME; Preusser M
Neuro Oncol; 2017 Oct; 19(11):1460-1468. PubMed ID: 28531337
[TBL] [Abstract][Full Text] [Related]
12. Identification of the immune gene expression signature associated with recurrence of high-grade gliomas.
Roura AJ; Gielniewski B; Pilanc P; Szadkowska P; Maleszewska M; Krol SK; Czepko R; Kaspera W; Wojtas B; Kaminska B
J Mol Med (Berl); 2021 Feb; 99(2):241-255. PubMed ID: 33215304
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive Prediction of IDH1 Mutation and ATRX Expression Loss in Low-Grade Gliomas Using Multiparametric MR Radiomic Features.
Ren Y; Zhang X; Rui W; Pang H; Qiu T; Wang J; Xie Q; Jin T; Zhang H; Chen H; Zhang Y; Lu H; Yao Z; Zhang J; Feng X
J Magn Reson Imaging; 2019 Mar; 49(3):808-817. PubMed ID: 30194745
[TBL] [Abstract][Full Text] [Related]
14. B2M overexpression correlates with malignancy and immune signatures in human gliomas.
Zhang H; Cui B; Zhou Y; Wang X; Wu W; Wang Z; Dai Z; Cheng Q; Yang K
Sci Rep; 2021 Mar; 11(1):5045. PubMed ID: 33658560
[TBL] [Abstract][Full Text] [Related]
15. Spatial immune heterogeneity of hypoxia-induced exhausted features in high-grade glioma.
Kim AR; Choi SJ; Park J; Kwon M; Chowdhury T; Yu HJ; Kim S; Kang H; Kim KM; Park SH; Park CK; Shin EC
Oncoimmunology; 2022; 11(1):2026019. PubMed ID: 35036078
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Radiomics Analyses Based on Different Magnetic Resonance Imaging Sequences in Grading and Molecular Genomic Typing of Glioma.
Huang WY; Wen LH; Wu G; Hu MZ; Zhang CC; Chen F; Zhao JN
J Comput Assist Tomogr; 2021 Jan-Feb 01; 45(1):110-120. PubMed ID: 33475317
[TBL] [Abstract][Full Text] [Related]
17. Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational status.
Grabner G; Kiesel B; Wöhrer A; Millesi M; Wurzer A; Göd S; Mallouhi A; Knosp E; Marosi C; Trattnig S; Wolfsberger S; Preusser M; Widhalm G
Eur Radiol; 2017 Apr; 27(4):1556-1567. PubMed ID: 27300198
[TBL] [Abstract][Full Text] [Related]
18. The Value of Enhanced MR Radiomics in Estimating the IDH1 Genotype in High-Grade Gliomas.
Niu L; Feng WH; Duan CF; Liu YC; Liu JH; Liu XJ
Biomed Res Int; 2020; 2020():4630218. PubMed ID: 33163535
[TBL] [Abstract][Full Text] [Related]
19. Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas.
Deng X; Lin D; Zhang X; Shen X; Yang Z; Yang L; Lu X; Yu L; Zhang N; Lin J
J Cell Physiol; 2020 Oct; 235(10):7321-7331. PubMed ID: 32162312
[TBL] [Abstract][Full Text] [Related]
20. Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas.
Zhang B; Chang K; Ramkissoon S; Tanguturi S; Bi WL; Reardon DA; Ligon KL; Alexander BM; Wen PY; Huang RY
Neuro Oncol; 2017 Jan; 19(1):109-117. PubMed ID: 27353503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
